In the space of a day, two AI stories broke into the mainstream. They were, in different ways and from different insider perspectives, about the same thing: becoming suddenly, and profoundly, worried ...

A marriage of formal methods and LLMs seeks to harness the strengths of both.

I'm sorry NixOS, I've failed you.

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

The surface of Earth is finite. We can measure it. If it was expanding, then its size would grow with time. And once again, good ol' Earth helps us understand what the universe might be doing beyond ...

Is the universe infinite? It's one of the most profound questions we can ask, and here's the short answer: We don't know. While we have learned a great deal about the universe, a portion of the cosmos ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...